Fatima, Maurish et al. published their research in European Journal of Internal Medicine in 2022 | CAS: 2492423-29-5

((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate (cas: 2492423-29-5) belongs to tetrahydrofuran derivatives. Tetrahydrofuran (THF), or oxolane, is mainly used as a precursor to polymers. Being polar and having a wide liquid range, THF is a versatile solvent. Commercial tetrahydrofuran contains substantial water that must be removed for sensitive operations, e.g. those involving organometallic compounds. Although tetrahydrofuran is traditionally dried by distillation from an aggressive desiccant, molecular sieves are superior.Computed Properties of C13H19N3O7

Efficacy and safety of molnupiravir for COVID-19 patients was written by Fatima, Maurish;Azeem, Saleha;Saeed, Junaid;Shahid, Abia;Cheema, Huzaifa Ahmad. And the article was included in European Journal of Internal Medicine in 2022.Computed Properties of C13H19N3O7 The following contents are mentioned in the article:

Our study include the inability to investigate more subgroups as we used study level data instead of individual patient data, and the unavailability of the results of two trials which may result in publication bias. We conducted this meta-anal. to increase the statistical power of the available evidence by combining it and evaluating the safety and efficacy of molnupiravir for the treatment of COVID-19 patients. It may be speculated that molnupiravir may only be effective in some subgroups of hospitalized patients; therefore, publication of the results of these trials might help in investigating this. In conclusion, our study supports the use of molnupiravir in non- hospitalized patients with COVID-19. Further research should be focused on evaluating its comparative efficacy in relation to other available treatments. This study involved multiple reactions and reactants, such as ((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate (cas: 2492423-29-5Computed Properties of C13H19N3O7).

((2R,3S,4R,5R)-3,4-Dihydroxy-5-((Z)-4-(hydroxyimino)-2-oxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-2-yl)methyl isobutyrate (cas: 2492423-29-5) belongs to tetrahydrofuran derivatives. Tetrahydrofuran (THF), or oxolane, is mainly used as a precursor to polymers. Being polar and having a wide liquid range, THF is a versatile solvent. Commercial tetrahydrofuran contains substantial water that must be removed for sensitive operations, e.g. those involving organometallic compounds. Although tetrahydrofuran is traditionally dried by distillation from an aggressive desiccant, molecular sieves are superior.Computed Properties of C13H19N3O7

Referemce:
Tetrahydrofuran – Wikipedia,
Tetrahydrofuran | (CH2)3CH2O – PubChem